Home

Salutare Bangladesh etico stada investor il motore Hong Kong Accusa

Annual Report 2022 | STADA
Annual Report 2022 | STADA

German pharma giant to ship billions of tablets from Vietnam to Europe
German pharma giant to ship billions of tablets from Vietnam to Europe

Stada Arzneimittel Management Braced for Battle With Activist Investors -  WSJ
Stada Arzneimittel Management Braced for Battle With Activist Investors - WSJ

Financial Reports - Investor Relations | STADA
Financial Reports - Investor Relations | STADA

Extraordinary General Meeting 2020 - Investor Relations | STADA
Extraordinary General Meeting 2020 - Investor Relations | STADA

STADA expands production network with project in Romania | STADA
STADA expands production network with project in Romania | STADA

STADA Arzneimittel AG - Your Partner in Health | STADA
STADA Arzneimittel AG - Your Partner in Health | STADA

News - Investor Relations | STADA
News - Investor Relations | STADA

Investor Relations | STADA
Investor Relations | STADA

Investor Relations | STADA
Investor Relations | STADA

Ad hoc Releases - Stock - Investor Relations | STADA
Ad hoc Releases - Stock - Investor Relations | STADA

News - Investor Relations | STADA
News - Investor Relations | STADA

STADA Arzneimittel AG - Your Partner in Health | STADA
STADA Arzneimittel AG - Your Partner in Health | STADA

Annual Report 2022 | STADA
Annual Report 2022 | STADA

News - Investor Relations | STADA
News - Investor Relations | STADA

STADA Arzneimittel AG - Your Partner in Health | STADA
STADA Arzneimittel AG - Your Partner in Health | STADA

Annual Report 2021 | STADA
Annual Report 2021 | STADA

News - Investor Relations | STADA
News - Investor Relations | STADA

Annual Report 2022 | STADA
Annual Report 2022 | STADA

Annual Report 2022 | STADA
Annual Report 2022 | STADA

STADA Arzneimittel AG - Your Partner in Health | STADA
STADA Arzneimittel AG - Your Partner in Health | STADA

Another activist investor jumps into Stada fray, lobbying for $4B-plus  private equity buyout | Fierce Pharma
Another activist investor jumps into Stada fray, lobbying for $4B-plus private equity buyout | Fierce Pharma